Comparing the efficacy and safety of tenofovir and adefovir or combined drug treatment for the treatment of chronic hepatitis B infection: a systematic review and meta-analysis

BACKGROUND: Chronic hepatitis B (CHB) affects a vast population globally. A variety of drugs are available for the treatment of CHB, including tenofovir (TDF) and adefovir (ADV). However, the efficacy of monotherapy drug treatment is inconclusive, the safety and efficacy of TDF remain unclear, more...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Zeyu, Wang, Ling, Hou, Huixin, Lu, Miao, Wang, Wei, Li, Zishuo, Liu, Chengjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577806/
https://www.ncbi.nlm.nih.gov/pubmed/36267714
http://dx.doi.org/10.21037/atm-22-3747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577806/
https://www.ncbi.nlm.nih.gov/pubmed/36267714
http://dx.doi.org/10.21037/atm-22-3747

Ejemplares similares